Morris Animal Foundation announced it is funding seven new studies focused on equid health, including pain management, vaccine development and foal sepsis.
“We are thrilled to be able to support these seven research projects, each focusing on major equid health issues,” said Dr. Kathy Tietje, Chief Program Officer at Morris Animal Foundation. “The Foundation continues to prioritize the health and welfare of horses through financial support for these innovative studies.”
The studies are slated to begin this year and will investigate a variety of equid health issues including:
- Nicholas Frank, Mississippi State University– Explore impact of cyproheptadine on blood variables and clinical signs of pituitary pars intermedia dysfunction in horses already receiving the drug pergolide.
- Noah Cohen, Texas A&M University– Develop an effective vaccine against strangles that can be administered intramuscularly to horses based on the “S” protein of Streptococcus equi subspecies equi (SEE) that can differentiate infected horses from vaccinated animals.
- Dianne McFarlane, University of Florida– Develop and apply a novel diagnostic test for equine pituitary pars intermedia dysfunction.
- Katarzyna Dembek, North Carolina State University– Increase understanding of foal sepsis and possible new treatment options.
- Canaan M. Whitfield-Cargile, University of Georgia– Examine the ability of a fecal-based test to aid in the diagnosis of gastric ulcers in horses.
- Hope Douglas, University of Pennsylvania– Study remote behavioral and physiologic monitoring to quantify and qualify changes in demonstrated equine discomfort behaviors and their association with epidural morphine administration.
- Constantinos Kurt Wibmer, University of the Witwatersrand, South Africa– Investigate drugs that will target the non-structural protein 4 of African horse sickness.
The post Morris Animal Foundation Funds Seven Studies To Advance Equid Health appeared first on Horse Racing News | Paulick Report.
